Core Alternative Capital’s Clorox CLX Stock Holding History

Core Alternative Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-86	Closed	-$13.6K	–	380
2023 Q1	$13.6K	Buy	+86	New	+$12.9K	﹤0.01%	268
2022 Q4	–	Sell	-6	Closed	-$1K	–	405
2022 Q3	$1K	Hold	6	–	–	﹤0.01%	413
2022 Q2	$1K	Hold	6	–	–	﹤0.01%	405
2022 Q1	$1K	Hold	6	–	–	﹤0.01%	402
2021 Q4	$1K	Buy	+6	New	+$1K	﹤0.01%	362

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Core Alternative Capital's CLX Position: Q2 2023 in Review

Core Alternative Capital sold out of Clorox (CLX) in Q2 2023, closing a stake of 86 shares — an estimated $13.6K sold.

Core Alternative Capital first reported a position in CLX in Q4 2021 and held it in 5 quarters. The position peaked at $13.6K in Q1 2023. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

Core Alternative Capital reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
Core Alternative Capital sold 86 Clorox shares in Q2 2023, an estimated $13.6K.
Core Alternative Capital first reported a position in Clorox in Q4 2021 and held it in 5 quarters.
Core Alternative Capital's Clorox position peaked at $13.6K in Q1 2023.
1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Core Alternative Capital's 13F filing for Q2 2023, filed 27 Jul 2023.